MSCopilot®, our class IIa Software as a Medical Device (SaMD) dedicated to the monitoring of people living with multiple sclerosis (MS), has received CE marking under the European Union Medical Device Regulation (EU MDR) 2017/745.
This certification confirms the safety, clinical performance and benefits of our digital solution, the result of over 10 years of clinical research in collaboration with expert centers and leading industry partners.
This marks a milestone for people living with MS, as well as for their families and the healthcare professionals who support them every day.
Check out our press release to discover all the details.